These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 9875597)

  • 1. Therapeutic drug monitoring of methadone in HIV-infected patients receiving protease inhibitors.
    Beauverie P; Taburet AM; Dessalles MC; Furlan V; Touzeau D
    AIDS; 1998 Dec; 12(18):2510-1. PubMed ID: 9875597
    [No Abstract]   [Full Text] [Related]  

  • 2. [Etiotropic combined therapy of HIV-infection].
    Rytik PG; Korzhev MO; Kucherov II; Podol'skaia IA; Sevkovskiĭ IaI
    Klin Med (Mosk); 2000; 78(5):13-8. PubMed ID: 10881501
    [No Abstract]   [Full Text] [Related]  

  • 3. [Special problems of HIV-positive women who are either drug abusers or on methadone replacement therapy].
    Isernhagen K
    Zentralbl Gynakol; 1999; 121(11):555-7. PubMed ID: 10612228
    [No Abstract]   [Full Text] [Related]  

  • 4. Methadone, adherence and protease inhibitors.
    Treat Rev; 1997 Aug; (No 25):2-3. PubMed ID: 11364614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Seropositivity. Antiretrovirus treatments].
    Tubiana R
    Soins; 1998; (622):19-23. PubMed ID: 9574066
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical resistance patterns and responses to two sequential protease inhibitor regimens in saquinavir and reverse transcriptase inhibitor-experienced persons.
    Lawrence J; Schapiro J; Winters M; Montoya J; Zolopa A; Pesano R; Efron B; Winslow D; Merigan TC
    J Infect Dis; 1999 Jun; 179(6):1356-64. PubMed ID: 10228055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of drug-to-drug interactions between cyclosporine A and the protease-inhibitor lopinavir/ritonavir in liver-transplanted HIV-infected patients.
    Vogel M; Voigt E; Michaelis HC; Sudhop T; Wolff M; Türler A; Sauerbruch T; Rockstroh JK; Spengler U
    Liver Transpl; 2004 Jul; 10(7):939-44. PubMed ID: 15237382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zidovudine overdose in an intravenous drug user.
    Selwyn PA; Iezza A
    AIDS; 1990 Aug; 4(8):822-4. PubMed ID: 2261143
    [No Abstract]   [Full Text] [Related]  

  • 9. Efficacy of low-dose boosted saquinavir once daily plus nucleoside reverse transcriptase inhibitors in pregnant HIV-1-infected women with a therapeutic drug monitoring strategy.
    Lopez-Cortes LF; Ruiz-Valderas R; Rivero A; Camacho A; Marquez-Solero M; Santos J; García-Lazaro M; Viciana P; Rodriguez-Baños J; Ocampo A
    Ther Drug Monit; 2007 Apr; 29(2):171-6. PubMed ID: 17417070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nevirapine-induced withdrawal symptoms in HIV patients on methadone maintenance programme: an alert.
    Otero MJ; Fuertes A; Sánchez R; Luna G
    AIDS; 1999 May; 13(8):1004-5. PubMed ID: 10371190
    [No Abstract]   [Full Text] [Related]  

  • 11. Mode of HIV transmission among seroconverted intravenous drug users (IVDUs): 1987 and 1988 cohort study.
    Nemoto T; Brown LS; Primm BJ; Foster K; Chu A
    NIDA Res Monogr; 1989; 95():407-8. PubMed ID: 2641011
    [No Abstract]   [Full Text] [Related]  

  • 12. Neuropsychological impairment among asymptomatic HIV-positive former intravenous drug users.
    Rodríguez Salgado D; Rodríguez Alvarez M; Seoane Pesqueira G
    Cogn Behav Neurol; 2006 Jun; 19(2):95-104. PubMed ID: 16783132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic interactions of nevirapine and methadone and guidelines for use of nevirapine to treat injection drug users.
    Clarke SM; Mulcahy FM; Tjia J; Reynolds HE; Gibbons SE; Barry MG; Back DJ
    Clin Infect Dis; 2001 Nov; 33(9):1595-7. PubMed ID: 11568856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adherence, side effects and efficacy of stavudine plus lamivudine plus nelfinavir in treatment-experienced HIV-infected patients.
    Roca B; Gómez CJ; Arnedo A
    J Infect; 2000 Jul; 41(1):50-4. PubMed ID: 10942640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV treatment options.
    Smith D
    AIDS Treat News; 1998 May; (No 294):4-5. PubMed ID: 11365404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can responses to antiretroviral therapy be improved by therapeutic drug monitoring?
    Haas DW
    Clin Infect Dis; 2006 Apr; 42(8):1197-9. PubMed ID: 16575742
    [No Abstract]   [Full Text] [Related]  

  • 17. Primary drug resistance in antiretroviral-naïve injection drug users.
    Tossonian HK; Raffa JD; Grebely J; Viljoen M; Mead A; Khara M; McLean M; Krishnamurthy A; DeVlaming S; Conway B
    Int J Infect Dis; 2009 Sep; 13(5):577-83. PubMed ID: 19111493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic interaction of nelfinavir and methadone in intravenous drug users.
    Hsyu PH; Lillibridge J; Daniels E; Kerr BM
    Biopharm Drug Dispos; 2006 Mar; 27(2):61-8. PubMed ID: 16299829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protease inhibitor plasma concentrations in HIV antiretroviral therapy.
    Justesen US
    Dan Med Bull; 2008 Nov; 55(4):165-85. PubMed ID: 19232158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Visceral leishmaniasis in HIV-infected patients with non-detectable HIV-1 viral load after highly active antiretroviral therapy.
    Jiménez-Expósito MJ; Alonso-Villaverde C; Sardà P; Masana L
    AIDS; 1999 Jan; 13(1):152-3. PubMed ID: 10207569
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.